News
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...
The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...
Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...
The FDA will no longer recommend annual COVID vaccinations for healthy people younger than 65. A North Carolina doctor says ...
The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company ...
"Political directives should not prevent individuals from seeking safe and effective care that they desire and deserve," ...
FDA approves Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk groups Phase 3 trial shows mNEXSPIKE outperforms original ...
The Food and Drug Administration (FDA) just green-lit a new Covid vaccine from Moderna, the company said in a press release ...
Health Secretary Robert F. Kennedy Jr.’s decision to revoke the Covid vaccine recommendation for pregnant women has raised ...
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results